{"version":"1.0","provider_name":"Nuvaira","provider_url":"https:\/\/nuvaira.com\/fr\/","title":"First Patient Treated in the AIRFLOW-4 trial - Nuvaira","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"U1ijAVylwT\"><a href=\"https:\/\/nuvaira.com\/fr\/blog\/200th-treatment-milestone-for-airflow-3-copd-trial\/\">First Patient Treated in the AIRFLOW-4 trial<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/nuvaira.com\/fr\/blog\/200th-treatment-milestone-for-airflow-3-copd-trial\/embed\/#?secret=U1ijAVylwT\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0First Patient Treated in the AIRFLOW-4 trial\u00a0\u00bb &#8212; Nuvaira\" data-secret=\"U1ijAVylwT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/nuvaira.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Lung Denervation Trial targets Novel COPD Phenotype First Patient Treated in the AIRFLOW-4 trial MINNEAPOLIS, July 1, 2026 \u2013 Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases has announced the first patient treated in its pivotal randomized trial of dNerva\u00ae targeted lung denervation therapy in COPD. dNerva\u00ae TLD is a one-time, [&hellip;]"}